Roivant Sciences

Roivant unveils new ‘vant’ to take forward Bayer’s inhaled hypertension med
Fierce Biotech
Tue, 09/10/24 - 08:56 am
Roivant Sciences
Bayer
pulmonary hypertension
mosliciguat
Vivek Ramaswamy wants to ‘gut’ the FDA
Stat
Mon, 07/31/23 - 09:48 pm
Vivek Ramaswamy
2024 Presidential election
FDA
Roivant Sciences
Roivant rises after long-term data for ulcerative colitis candidate
Seeking Alpha
Thu, 06/22/23 - 10:14 am
Roivant Sciences
clinical trials
ulcerative colitis
TVT-3101
IPOs vs SPACs
EP Vantage
Thu, 03/9/23 - 09:47 am
IPOs
SPAC
Belite Bio
Cerevel Therapeutics
NewAmsterdam Pharma
Nuvectis Pharma
Oculis
Roivant Sciences
Biotech leader and ex-CEO of Roivant Sciences Ramaswamy may consider running for president as a Republican
Politico
Tue, 02/14/23 - 10:37 am
2024 Presidential election
Vivek Ramaswamy
Roivant Sciences
Roivant’s Matt Gline on the hub-and-spoke biotech model and lessons learned from Axovant
Biopharma Dive
Mon, 01/23/23 - 09:45 pm
Roivant Sciences
IBD
Pfizer
Matt Gline
hub-and-spoke
Fresh from Pfizer deal, Roivant posts 'best-in-class' ulcerative colitis data on rival to Prometheus prospect
Fierce Biotech
Wed, 01/4/23 - 05:22 pm
Roivant Sciences
ulcerative colitis
clinical trials
RVT-3101
Roivant decants another Vant armed with Eisai blood cancer drug and plans to start phase 1/2 soon
Fierce Biotech
Mon, 02/14/22 - 12:05 pm
Hemavant
Roivant Sciences
Eisai
MDS
RVT-2001
Immunovant Shares Drop After Roivant Opts for Strategic Investment
Marketwatch
Mon, 08/2/21 - 11:04 am
Immuovant
Roivant Sciences
Roivant’s move to go public reveals just how much its drug strategy has changed
MedCity News
Tue, 05/4/21 - 10:39 pm
Roivant Sciences
Vivek Ramaswamy